| Views | |
|---|---|
| Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 | 42 |
| November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | |
|---|---|---|---|---|---|---|---|
| Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 | 2 | 0 | 0 | 0 | 0 | 3 | 4 |
| Views | |
|---|---|
| dic.2022-1-125955.pdf | 9 |
| Views | |
|---|---|
| Canada | 23 |
| Russia | 7 |
| United States | 3 |
| United Kingdom | 2 |
| A2 | 1 |
| China | 1 |
| Japan | 1 |
| Vietnam | 1 |
| Views | |
|---|---|
| Ottawa | 23 |
| Hanoi | 1 |
| Hartlepool | 1 |
| Tokyo | 1 |
| Washington | 1 |